2-(Oxiran-2-ylmethyl)-1H-isoindole-1,3(2H)-dione, 97.0%, 25g

4-Chloro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 96%, 250mg

(3R,4S)-1-(tert-Butoxycarbonyl)-4-(4-cyanophenyl)pyrrolidine-3-carboxylic acid, 95.0%, 100mg

8-Fluoroquinoline>97.0%(GC)5g

3-(2-methoxyphenoxy)azetidine hydrochloride, 95.0%, 5g

1-(3-nitrobenzyl)piperazine hydrochloride, 95.0%, 5g

4-TERT-BUTOXYBENZONITRILE, 95.0%, 5g

3-allyl-4-(allyloxy)-5-methoxybenzaldehyde, 95.0%, 5g

5-Methylpyrrolo[2,1-f][1,2,4]triazin-4(1H)-one, 95.0%, 1g

2-Methanesulfonyl-thioacetamide, 95.0%, 5g

(1 H -Indol-3-ylmethyl)-(2-methoxy-benzyl)-amine, 95.0%, 1g

Colonna capillare per GC ROTI®Cap-1, 25 m, 0,25 mm, 0,10 µm, 1 Pezzo(i)

6-CHLORO-1H-PYRAZOLO[3,4-B]PYRIDINE-4-CARBOXYLIC ACID, 95%, 100mg